Table 2.
Patients |
Healthy volunteers |
||||||
---|---|---|---|---|---|---|---|
Core | Penumbra | Peri-penumbra | Normal appearing | P-valuea | P-valueb | ||
K1, ml/ml/min | 0.039 (0.021)c,d | 0.049 (0.018)c | 0.084 (0.022)e | 0.091 (0.025) | <0.001 | 0.091 (0.007) | 0.720 |
k2,/min | 0.154 (0.069) | 0.131 (0.048)c | 0.156 (0.052) | 0.173 (0.055) | <0.001 | 0.128 (0.029) | <0.001 |
k3,/min | 0.044 (0.021)c,d | 0.039 (0.010)c | 0.030 (0.012) | 0.029 (0.010) | <0.001 | 0.057 (0.009) | <0.001 |
Ki, ml/ml/min | 0.009 (0.006)c,d | 0.012 (0.004) | 0.014 (0.004) | 0.013 (0.005) | <0.001 | 0.034 (0.008) | <0.001 |
CMRG, µmol/100 ml/min | 11.9 (5.4)c,d | 14.9 (4.3)c | 19.5 (4.1)e | 19.9 (4.9) | <0.001 | 26.3 (1.9) | <0.001 |
LC | 0.48 (0.07)c,d | 0.47 (0.05)c | 0.43 (0.05)e | 0.41 (0.04) | <0.001 | 0.56 (0.04) | <0.001 |
CBF, ml/100 ml/min | 12.2 (10.7)c,d | 18.1 (6.4)c | 27.4 (8.1)e | 28.6 (4.9) | <0.001 | 42.9 (11.5) | <0.001 |
CBV, ml/100 ml | 2.7 (0.9)c,d | 2.8 (0.8)c | 3.5 (0.9)e | 4.3 (0.9) | <0.001 | 3.5 (0.5) | <0.001 |
CMRO2, µmol/100 ml/min | 29.6 (23.8)c,d | 45.6 (20.6)c | 71.9 (27.3)e | 82.1 (30.5) | <0.001 | 139.0 (39) | <0.001 |
OEF, % | 30.0 (20.1)c,d | 38.5 (14.4) | 42.3 (12.2) | 42.1 (10.4) | <0.001 | 43.9 (4.5) | 0.685 |
Metabolic ratio | 2.6 (1.3)c,d | 2.9 (0.8)c | 4.0 (1.2)e | 4.0 (1.2) | <0.001 |
18F-FDG kinetic parameters, CMRG, lumped constant (LC), CBF, CBV, CMRO2, OEF and CMRO2/CMRG metabolic ratio for the different regions of interest in patients and healthy volunteers. Values are median (IQR).
Kruskal-Wallis test for comparison between core, penumbra, peri-penumbra and normal-appearing regions of interest within patients, with subsequent post hoc Dunn’s tests surviving correction for multiple comparisons (P < 0.005) between each lesion region of interest and normal-appearing brainc, between core and peri-penumbrad, and between peri-penumbra and penumbrae.
Mann-Whitney U-test for comparison between the normal-appearing region of interest in patients versus healthy volunteers.